June 02, 2022
2 min watch
Save
VIDEO: Cellular therapy administration best practices; new drug regiments for multiple myeloma discussed at ONS
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
In this video, Yael Malul, MSN, RN, AGACNP-BC, OCN, discussed presentations on immune effector cell administration best practices and new treatment strategies for multiple myeloma at Oncology Nursing Society Congress 2022.
Malul said that it was rewarding to be at the session on new drug regiments and strategies for multiple myeloma since her clinical trials unit has been involved in many of the trials that led to the approvals of the therapies that were discussed.
"It felt very empowering to see those drugs up on a screen and to talk about how much progress we've made with multiple myeloma patients and treatment availability," Malul said.
Published by:
Sources/Disclosures
Collapse
Source:
Lenzo J, et al. Nursing Research Unit Standard Operating Procedure to Guide Administration of Investigational Immune Effector Cell Therapy. Presented at: ONS Congress; April 27-May 1, 2022; Anaheim.
Disclosures:
Malul reports no relevant financial disclosures.
Read more about
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.